Prim S.A (PRM) | Financial Analysis & Statements
Prim S.A. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2021Income Metrics
Revenue
44.5M
Gross Profit
22.4M
50.44%
Operating Income
6.0M
13.41%
Net Income
4.5M
10.21%
Balance Sheet Metrics
Total Assets
196.5M
Total Liabilities
58.9M
Shareholders Equity
137.6M
Debt to Equity
0.43
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2021
Annual Income Flow
2025
Prim S.A Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 251.8M | 233.1M | 216.5M | 197.2M | 168.5M |
| Cost of Goods Sold | 124.8M | 120.5M | 109.7M | 102.7M | 85.4M |
| Gross Profit | 127.0M | 112.6M | 106.8M | 94.6M | 83.1M |
| Gross Margin % | 50.4% | 48.3% | 49.3% | 47.9% | 49.3% |
| Operating Expenses | |||||
| Research & Development | - | 14.3K | 22.3K | 2.8K | 0 |
| Selling, General & Administrative | - | 28.4M | 27.2M | 25.7M | 19.0M |
| Other Operating Expenses | 35.0M | 32.1M | 2.0M | 2.3M | 1.7M |
| Total Operating Expenses | 35.0M | 60.5M | 29.2M | 28.0M | 20.8M |
| Operating Income | 22.5M | 15.7M | 15.9M | 11.6M | 17.2M |
| Operating Margin % | 8.9% | 6.7% | 7.3% | 5.9% | 10.2% |
| Non-Operating Items | |||||
| Interest Income | 573.0K | 482.0K | 429.9K | 974.8K | 956.5K |
| Interest Expense | 538.0K | 774.0K | 826.4K | 280.7K | 134.8K |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 21.8M | 14.3M | 17.0M | 10.9M | 23.1M |
| Income Tax | 5.1M | 3.4M | 4.4M | 2.5M | 5.6M |
| Effective Tax Rate % | 23.5% | 23.8% | 25.6% | 22.8% | 24.4% |
| Net Income | 16.7M | 10.9M | 12.7M | 8.4M | 17.4M |
| Net Margin % | 6.6% | 4.7% | 5.9% | 4.3% | 10.3% |
| Key Metrics | |||||
| EBITDA | 33.5M | 27.2M | 26.4M | 21.4M | 25.0M |
| EPS (Basic) | €0.98 | €0.64 | €0.74 | €0.49 | €1.01 |
| EPS (Diluted) | €0.98 | €0.64 | €0.74 | €0.49 | €1.01 |
| Basic Shares Outstanding | 1701239447 | 1701024773 | 17010248 | 17059595 | 17220202 |
| Diluted Shares Outstanding | 1701239447 | 1701024773 | 17010248 | 17059595 | 17220202 |
Income Statement Trend
Prim S.A Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 18.3M | 9.6M | 6.4M | 10.9M | 32.3M |
| Short-term Investments | 4.7M | 4.1M | 6.8M | 4.1M | 4.3M |
| Accounts Receivable | 48.6M | 49.6M | 61.8M | 45.7M | 37.1M |
| Inventory | 67.3M | 65.2M | 66.6M | 64.1M | 56.3M |
| Other Current Assets | 440.0K | 100 | - | - | - |
| Total Current Assets | 140.9M | 134.9M | 144.5M | 131.4M | 135.9M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | - | 7.7M | 8.1M | 7.5M | 31.6M |
| Goodwill | 34.6M | 35.5M | 33.3M | 28.1M | 14.3M |
| Intangible Assets | 11.7M | 12.8M | 14.2M | 9.8M | 4.4M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | - | - | - | - | 52.5K |
| Total Non-Current Assets | 55.7M | 55.4M | 55.6M | 53.6M | 43.9M |
| Total Assets | 196.5M | 190.3M | 200.1M | 185.0M | 179.8M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 25.3M | 22.2M | 24.6M | 18.2M | 24.0M |
| Short-term Debt | 8.3M | 11.9M | 17.6M | 10.3M | 8.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | -10.3M | - |
| Total Current Liabilities | 47.1M | 49.4M | 62.1M | 48.7M | 45.9M |
| Non-Current Liabilities | |||||
| Long-term Debt | 7.2M | 7.6M | 8.5M | 11.8M | 11.0M |
| Deferred Tax Liabilities | 2.1M | 2.2M | 2.4M | 1.3M | 620.4K |
| Other Non-Current Liabilities | 813.0K | 59.7K | 96.9K | 2.9M | 624.7K |
| Total Non-Current Liabilities | 11.8M | 11.9M | 12.2M | 16.6M | 12.5M |
| Total Liabilities | 58.9M | 61.3M | 74.3M | 65.3M | 58.4M |
| Equity | |||||
| Common Stock | 4.3M | 4.3M | 4.3M | 4.3M | 4.3M |
| Retained Earnings | 16.7M | 10.9M | 12.7M | 8.4M | 17.4M |
| Treasury Stock | 280.0K | 237.5K | 266.5K | 1.2M | 3.1M |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 137.6M | 128.9M | 125.8M | 119.7M | 121.5M |
| Key Metrics | |||||
| Total Debt | 15.5M | 19.6M | 26.1M | 22.1M | 19.0M |
| Working Capital | 93.8M | 85.5M | 82.4M | 82.6M | 90.0M |
Balance Sheet Composition
Prim S.A Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | - | - | - | - | - |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | 0 | 0 | 0 | 0 | 0 |
| Operating Cash Flow | - | - | - | - | - |
| Investing Activities | |||||
| Capital Expenditures | -12.3M | -11.3M | -8.8M | -11.8M | -11.6M |
| Acquisitions | 0 | -960.0K | 2.8M | -6.7M | -419.1K |
| Investment Purchases | - | - | - | - | -16.7K |
| Investment Sales | 3.0M | 1.4M | 3.4M | 3.4M | 2.3M |
| Investing Cash Flow | -10.6M | -10.7M | -2.6M | -15.0M | -9.7M |
| Financing Activities | |||||
| Share Repurchases | -3.3M | -3.4M | -26.6K | -1.1M | -2.9M |
| Dividends Paid | -8.0M | -7.6M | -6.2M | -8.8M | -5.4M |
| Debt Issuance | - | 13.6M | 20.1M | 2.0M | 0 |
| Debt Repayment | - | -17.0M | -3.1M | -4.7M | -8.7M |
| Financing Cash Flow | -11.3M | -17.9M | 64.6M | -15.8M | -23.8M |
| Free Cash Flow | 18.1M | 10.8M | -21.7M | -7.0M | 12.1M |
| Net Change in Cash | -21.9M | -28.6M | 62.1M | -30.8M | -33.5M |
Cash Flow Trend
Prim S.A Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
13.42
Forward P/E
10.10
Price to Book
1.63
Price to Sales
0.89
PEG Ratio
10.10
Profitability Ratios
Profit Margin
6.62%
Operating Margin
7.14%
Return on Equity
12.52%
Return on Assets
6.73%
Financial Health
Current Ratio
2.99
Debt to Equity
11.24
Beta
0.52
Per Share Data
EPS (TTM)
€0.98
Book Value per Share
€8.09
Revenue per Share
€14.80
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| PRM | 225.4M | 13.42 | 1.63 | 12.52% | 6.62% | 11.24 |
| Grifols, S.A | 6.1B | 15.58 | 1.19 | 6.17% | 5.34% | 126.83 |
| Laboratorios | 4.3B | 36.12 | 6.59 | 22.33% | 18.89% | 18.04 |
| Almirall S.A | 2.8B | 58.64 | 1.86 | 3.10% | 4.14% | 23.30 |
| Pharma Mar S.A | 1.7B | 21.87 | 6.48 | 32.59% | 33.87% | 19.62 |
| Faes Farma S.A | 1.5B | 19.60 | 2.05 | 10.82% | 12.70% | 58.11 |
Financial data is updated regularly. All figures are in the company's reporting currency.





